Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -71.07M | -69.14M | -78.17M | -64.29M | 5.16M |
| Total Depreciation and Amortization | 1.85M | 1.73M | 1.62M | 1.37M | 1.11M |
| Total Amortization of Deferred Charges | -- | 50.00K | 58.00K | 67.00K | 75.00K |
| Total Other Non-Cash Items | 7.66M | 1.16M | 9.46M | -3.32M | -70.92M |
| Change in Net Operating Assets | -746.00K | -3.14M | 1.14M | 1.17M | 3.36M |
| Cash from Operations | -62.31M | -69.34M | -65.90M | -65.01M | -61.21M |
| Capital Expenditure | -1.67M | -1.62M | -2.29M | -3.64M | -5.35M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.11M | -50.20M | -49.67M | -43.52M | -- |
| Cash from Investing | -45.78M | -51.82M | -51.96M | -47.16M | -5.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.00K | -928.00K | -1.09M | -1.25M | -1.40M |
| Issuance of Common Stock | 47.34M | 57.33M | 10.54M | 10.59M | 10.84M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.62M | -2.92M | -100.00K | -100.00K | -300.00K |
| Cash from Financing | 44.70M | 53.48M | 9.35M | 9.24M | 9.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.39M | -67.68M | -108.51M | -102.93M | -57.42M |